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Revertant Mosaicism in Epidermolysis Bullosa
Caused by Mitotic Gene Conversion
Marcel F. Jonkman,* Hans Scheffer,† Type XVII collagen, a structural component of hemi-
Rein Stulp,† Hendri H. Pas,* desmosomes, is a type II transmembrane molecule with
Miranda Nijenhuis,* Klaas Heeres,* the amino-terminal globular domain orientated intracel-
Katsushi Owaribe,‡ Leena Pulkkinen,§ lularly (Giudice et al., 1992). The extracellular portion
and Jouni Uitto§ contains an interrupted collagenous domain, which is
*Department of Dermatology the reason why the protein is added to the family of
University Hospital Groningen collagens (Li et al., 1993). Ultrastructurally, the extracel-
NL-9700 RB Groningen lular portion of type XVII collagen is associated with
The Netherlands anchoring filaments, which span the lamina lucida and
†Department of Medical Genetics connect the hemidesmosomal plaque with the base-
University of Groningen ment membrane (Nishizawa et al., 1993). The corre-
NL-9713 AW Groningen sponding gene COL17A1, which has been mapped to
The Netherlands chromosome 10q24.3 (Li et al., 1991), consists of 56
‡Department of Molecular Biology exons ranging in size from 27 to 390 nt, and spans 52
Nagoya University School of Medicine kb of genomic DNA (Gatalica et al., 1997).
Nagoya-Shi 464–01 Recently, we demonstrated a mosaic pattern of immu-
Japan noreactive type XVII collagen in clusters of basal cells
§Department of Dermatology and Cutaneous Biology in patches of clinically unaffected skin in a Dutch GABEB
Jefferson Medical College patient, in whom the remainder of the skin demonstrated
Philadelphia, Pennsylvania 19107 characteristic blistering from mechanical trauma (Jonk-
man et al., 1995, 1996). In this study, we demonstrate
that the mosaic phenotype in this patient was caused
Summary by reversion of one of the mutations in the COL17A1
gene. We also demonstrate that the reverse mutation
Mitotic gene conversion acting as reverse mutation was the result of the nonreciprocal transfer of a part of
has not been previously demonstrated in human. We one parental allele for the other by a mechanism that is
report here that the revertant mosaicism of a com- designated mitotic gene conversion. The natural gene
pound heterozygous proband with an autosomal re- therapy reported here has implications for the design
cessive genodermatosis, generalized atrophic benign
of gene therapy, since reversion of the affected geno-
epidermolysis bullosa, is caused by mitotic gene con-
type to carrier genotype of approximately 50% of the
version of one of the two mutated COL17A1 alleles.
basal keratinocytes appears to besufficient tonormalizeSpecifically, the maternal allele surrounding the muta-
the function of the skin, as noted in clinically unaffectedtion site on COL17A1 (1706delA) showed reversion of
skin patches of the patient with this autosomal recessivethe mutation and loss of heterozygosity along a tract
disorder.of at least 381 bp in revertant keratinocytes derived
from clinically unaffected skin patches; the paternal
mutation (R1226X) remained present in all cell sam-
Resultsples. Revertant mosaicism represents a way of natural
gene therapy.
Demonstration of Clinical and Cellular Mosaicism
The propositus was a 28-year-old female with unrelatedIntroduction
parents. The parents, as well as seven of her siblings,
were clinically normal (cf. Figure 6). She also had anType XVII collagen, alternatively named bullous pemphi-
older brother with a history of similar blistering, whogoid antigen 2 (BPAG2, BP180, or HD-4), is a 180 kDa
died at the age of one year from complications of thetransmembrane cell-matrix adhesion molecule located
disease. This fact rules out the possibility that the dis-in the hemidesmosomes of stratified squamous epithe-
ease in the proband and its mosiac presentation (de-lia. Mutations in COL17A1, the gene for type XVII colla-
scribed below) were caused by a de novo mutation ingen, cause generalized atrophic benign epidermolysis
one of the parental alleles, since both parents must havebullosa (GABEB) (McKusick 22665) (Jonkman et al.,
transmitted a mutant allele to the two affected children.1995; McGrath et al., 1995, 1996; H. S. et al., submitted),
The proband displayed typical features of GABEB: gen-suggesting that it plays a critical role in maintaining
eralized blistering afterminor traumaresulting in cutane-the integrity of the basement membrane zone. GABEB,
ous atrophy, mild mucous membrane involvement, uni-inherited in an autosomal recessive pattern, is charac-
versal alopecia, pigmentary changes, dental anomalies,terized by continuous blistering since birth with loss of
and nail dystrophy. There was no evidence of scarringhair in infancy, presence of dental anomalies, and nail
or milia formation.dystrophy (Hintner and Wolff, 1982; Fine et al., 1991;
Physical examination disclosed patches of clinicallyJonkman et al., 1996). The split level of the blisters is
unaffected skin in a symmetrical leaf-like (phylloid) pat-of the junctional type, i.e., through the lamina lucida of
the dermal–epidermal basement membrane zone. tern over the extensor surface of hands and upper arms
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laminin-5, and type VII collagen, revealed normal stain-
ing (data not shown). Immunofluorescence for type XVII
collagen in the skinof the parents was normal ina contin-
uous pattern.
Transmission electron microscopy of the proband’s
fragile skin, after gentle rubbing, revealed the plane of
cleavage within the lamina lucida. Perilesional skin from
the affected area demonstrated the presence of a
reduced number of hypoplastic hemidesmosomes,
whereas in the samples of clinically unaffected skin,
basal cells with normal appearing hemidesmosomes
were seen adjacent to those with hypoplastic hemides-
mosomes.
Essentially, all (98%–100%) of cultured keratinocytes
Figure 1. Clinically Unaffected Patches of Skin with Phylloid Pattern
derived from clinically unaffected skin were type XVIIin the Mosaic Proband with Generalized Atrophic Benign Epidermol-
collagen-positive by immunofluorescence (data notysis Bullosa
shown). In vivo, however, the fraction of type XVII colla-Patches of skin that never blister (outlined with a solid line) show
gen-positive basal cells in the clinically unaffected skinnormal pigmentation.
was approximated 50%. Therefore, the type XVII colla-
gen-positive keratinocytes apparently had a selective
growth advantage in vitro. These cells were isolated by(Figure 1). These patches covered about 10% of the
a fluorescence-activated cell sorter (FACS) for subse-total body surface area. In these clinically unaffected
quent DNA studies. The type XVII collagen-negativemosaic skin patches, we could not evoke blisters,
cells, ,2% of the cultured keratinocytes, were too fewwhereas the complementary skin showed blisters after
in number to allow their isolation by FACS, since thisgentle rubbing. Some of the clinically unaffected skin
fraction was contaminated by type XVII collagen-posi-patches were new and expanded slowly with the years,
tive keratinocytes. We therefore excluded the type XVIIwhile other patches had been present as long as she
collagen-negative cell fraction derived from clinicallycan remember and remained stationary.
unaffected skin for further genetic studies, and usedImmunofluorescence staining with monoclonal anti-
the unsorted type XVII collagen-negative keratinocytesbodies (1D1, 1A8c) against type XVII collagen was nega-
derived from clinically affected skin for comparison.tive in biopsy specimens of the clinically affected skin.
Gross chromosomal aberrations were not detected bySurprisingly, however, in the clinically unaffected mo-
karyotyping of the proband’s fibroblasts (data notsaic patches type XVII collagen was present in approxi-
shown).mately 50% of the basal cells, although in a slightly
reduced intensity. The positive cells were in groups of
about 10–50 adjacent cells (Figure 2). Staining for an- Identification of the Paternal COL17A1 Mutation
other hemidesmosomal adhesion molecule a6b4 inte- We concluded that the gene for type XVII collagen,
grin showed a normal continuous pattern at the dermal– COL17A1, may be the candidate gene for mutations in
epidermal junction by dual fluorescence microscopy this patient. Consequently, we scanned COL17A1 for
(Figure 2). Similarly, other basement membrane zone putative pathogenetic mutations using the strategy
components, including plectin/HD-1, BPAG1, laminin-1, based on PCR amplification of genomic DNA followed
by heteroduplex analysis. In case of evidence for a se-
quence variant, i.e., the presence of a heteroduplex,
the PCR product was subjected to direct automated
sequencing. Utilizing this strategy, we found a hetero-
duplex in the proband’s and father’s PCR product corre-
sponding to exon 51 sequence within COL17A1 (Figure
3A). Direct sequencing of the PCR product revealed a
nonsense mutation at nt 3781 (Figure 3B). Restriction
enzyme analysis revealed that the paternal mutation re-
mained present in all DNA samples of the proband (Fig-
ure 3C). The paternal mutation was therefore not in-
volved in the mosaicism.
Figure 2. Micromosaicism of Type XVII Collagen-Positive Basal
Identification of the Maternal COL17A1 MutationCells in Clinically Unaffected Skin of the Proband
Similar mutation detection strategy resulted in appear-(A) Immunofluorescence microscopy with monoclonal antibody
against type XVII collagen epitope shows a linear pattern along the ance of a band with faster mobility in the case of the
dermal–epidermal junction with negative interruptions of approxi- proband and the mother when PCR products corre-
mately 150 mm. sponding to exon 18 of COL17A1 were examined (Figure
(B) Dual immunofluorescence microscopy of the same section 4A). Sequencing of these PCR products revealed a
shown in (A) displaying type XVII collagen in green and the integrin
1-base deletion of nucleotide A at cDNA position 1706b4 subunit in red. Integrin b4 is expressed by all basal cells. Yellow
(Figure 4B). This mutation, 1706delA, resulted in afluorescence is seen on sites where both antigens are present. The
nuclei are counterstained in blue with bizbenzimide. Bar: 50 mm. frameshift and a premature termination codon 54 bp
Reverent Mosaicism by Mitotic Gene Conversion
545
Figure 3. Identification of the Paternal COL17A1 Mutation Figure 4. Identification of the Maternal COL17A1 Mutation
(A) Heteroduplex analysis of PCR products of COL17A1 showed a (A) Heteroduplex analysis showed a shift with PCR products span-
heteroduplex band DNA containing the 147 bp exon 51 segment in ning the 222 bp exon 18 and flanking intronic sequences from the
the father’s (lane 1) and proband’s (lane 3) leukocyte DNA samples, mother’s (lane 2) and proband’s (lane 3) leukocyte DNA, but not
but not in that of the mother (lane 2) or the control sample (lane 4). from that of the father’s (lane 1) or the control sample (lane 4).
(B) Direct sequencing of the PCR product spanning exon 51 revealed (B) Direct sequencing of the PCRproduct spanningexon 18 revealed
a heterozygous C-to-T transition at cDNA position 3781, which a heterozygous 1 bp deletion of nucleotide A at cDNA position
changes an arginine (CGA) to a stop codon (TGA) in the father and 1706, resulting in frameshift in the mother’s and in the proband’s
in the proband. leukocytes.
(C) This mutation, designated R1226X, results in the loss of a restric- (C) This mutation, designated 1706delA, was verified by allele-spe-
tion enzyme site for TaqI. The mother’s (lane 2) and control PCR cific oligonucleotide hybridization (ASO). The mutation was present
products (lane 9) are digested into 185 bp and 157 bp fragments, in DNA derived from the mother’s (lane 2) and proband’s leukocytes
whereas the father’s (lane 1) and proband’s PCR products (lane 3–8) (lane 3), and fibroblasts from the unaffected skin (lane 6), as well
have a 342 bp band in addition to the 185 bp and 157 bp fragments, as keratinocytes (lane 7) and fibroblasts (lane 8) from the affected
indicating heterozygosity for the mutant allele. The R1226X mutation skin of the proband. A plasmid containing the mutation (lane 11)
was present in heterozygous state in DNA derived from the pro- was used as control. This mutation was absent in the father’s DNA
band’s leukocytes (lane 3), as well as in DNA derived from unsorted (lane 1) and in DNA derived from unselected (lane 4) and type XVII
keratinocytes (lane 4), and type XVII collagen-positive keratinocytes collagen-positive (lane 5) keratinocytes from proband’s clinically
(lane 5) and fibroblasts (lane 6) from proband’s clinically unaffected unaffected skin. DNA from a normal individual (lane 9) and a plasmid
skin, as well as from keratinocytes (lane 7) and fibroblasts (lane containing the wild-type sequence (lane 10) were used as controls.
8) from proband’s clinically affected skin. M: PhiX 174 DNA/HalIII
molecular weight markers.
maternal allele in DNA from proband’s WT/R1226X kera-
tinocytes (Figure 6). This discovery makes back muta-
downstream from the deletion. This maternal mutation tion by insertion of the deleted single nucleotide A un-
was not present in type XVII collagen-positive keratino- likely, since the reverse mutation involved both the
cytes from the clinically unaffected skin of the proband, maternal mutationand the neighboringintragenic micro-
in contrast to the other cell samples of the proband, satellite.
including fibroblasts cultured from the same skin biopsy A possible deletion in COL17A1 was excluded by sev-
(Figure 4C). eral observations. First, PCR amplification of genomic
The revertant keratinocytes expressed type XVIIcolla- DNA segment spanning from intron 16 to intron 19
gen in reduced amounts at the protein level (Figure 5). showed only a single band (1892 bp) on agarose gel
Thus, the proband was a compound heterozygote electrophoresis in all DNA samples of the proband, in-
(COL17A1: 1706delA/R1226X) with a reverse mutation cluding leukocytes and fibroblasts, as well as 1706delA/
abolishing the maternal mutation in type XVII-positive R1226X and WT/R1226X keratinocytes (data not shown).
keratinocytes (COL17A1: WT/R1226X). Second, direct sequencing of these amplimers showed
no nucleotide deletions, and the 1 bp polymorphism in
intron 19 (Figure 6) was still present heterozygously inThe Molecular Mechanism of the Reverse Mutation
Analysis of a microsatellite polymorphism within intron these PCR products. A deletion of exons 17, 18, and
19, which could shorten the protein by as much as 1518 of COL17A1 located 381 bp downstream from the
maternal mutation in exon 18 revealed a loss of the kDa, was therefore excluded. Third, a larger deletion
Cell
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Figure 5. The Revertant (WT/R1226X ) Keratinocytes Express Nor-
mal Length Type XVII Collagen Protein at Reduced Levels
Western blot of protein extracts of keratinocytes from clinically unaf-
fected (lanes 1 and 4) and affected (lanes 2 and 5) skin of the
proband, and from keratinocytes of a normal individual (lanes 3
and 6), using type XVII collagen monoclonal antibody (lanes 1–3) or
serum from a patient with bullous pemphigoid (lanes 4–6). Proband’s
WT/R1226X keratinocytes show reduced level of normal length type
XVII collagen protein of the approximate size of 180 kDa. Type XVII
collagen is undetectable in 1706delA/R1226X keratinocytes. Note
that a 120 kDa antigen, recognized by the bullous pemphigoid se-
rum, is reduced in WT/R1226X keratinocytes and undetectable in
1706delA/R1226X keratinocytes.
was excluded by Western blot analysis, which revealed
that keratinocytes from proband’s clinically unaffected Figure 6. Loss of Heterozygosity at the Region of Maternal Mutation
skin produced type XVII collagen of normal length (Fig- in the Revertant Keratinocytes of the Proband
ure 5). This apparently stable protein of normal length The pedigree of the family with generalized atrophic benign epider-
molysis bullosa is shown (top). The COL17A1-CA1 microsatellitemust beproduced by a reverted allele, since bothmutant
within intron 18 of the parents’ and of the proband’s 1706delA/alleles contained a genetic lesion predicting synthesis
R1226X peripheral blood cells (PBC) and WT/R1226Xtype XVII colla-of an instable truncated polypeptide (McGrath et al.,
gen-positive revertant keratinocytes (K1) run on denaturing poly-
1995). acrylamide gel (middle) show loss of the maternal repeat in K1.
Haplotype analysis of the polymorphic markers flank- The genetic map of the polymorphic loci is given (bottom). The
microsatellite markers flanking the COL17A1 gene (10q23–25) areing COL17A1 on chromosome 10q24.3 showed hetero-
indicated by 1 for the largest allele, by 2 for the next shorter allele,zygosity in the revertant keratinocytes (Figure 6). This
etc. Polymorphisms within the COL17A1 gene are indicated by nu-result excludes mitotic nondisjunction and single intra-
cleotide, sensitivity for restriction enzyme, or rank number of allele
genic crossing-over between the sites of the paternally size. The pathogenic mutations are typed in bold. The haplotypes
and maternally derived mutations as an explanation for that have been transmitted are boxed.
the reverse mutation.
Thus, the conversion tract (segment of nonrecipro-
cally exchanged DNA) spanned at least 381 bp ex- recessive junctional epidermolysis bullosa causes re-
tending from the maternal mutation in exon 18 to the version of the phenotype in a mosaic pattern. This find-
microsatellite in intron 18. This exchange may have been ing of a reverse mutation in human is remarkable, be-
caused by a double crossing-over during mitosis, which cause the genetic mechanism is demonstrated to be
we considered very unlikely (cf. Discussion), or by a gene conversion.
mitotic gene conversion. Due to the lack of observed
heterozygosity within the sequences of introns 3 to 17,
the major part of which has been sequenced, the length Molecular Mechanisms of Reverse
of the conversion tract of DNA cannot be determined Mutation in Somatic Mosaicism
with more accuracy,because lossor retension of hetero- Somatic mosaicism mostly refers to clinically altered
zygosity cannot be analyzed. Sequencing of additional patches of tissue as a result of deleterious effects of a
upstream intronic sequences is currently in progress. gross chromosomal abnormality or a single gene muta-
tion (Hall, 1988). In the event of mutation during mitosis
of somatic cells that originate from a single zygote, two
Discussion or more genetically different populations of cells will
develop. After somatic mutation, the mosaic tissue con-
This study presents evidence that mitotic gene conver- tains mutant cells that stand out against the background
sion of one parental mutation in the COL17A1 gene of wild-type cells. Clinically, this may result in tumorigen-
esis (Cavenee et al., 1983) or, in the skin, lead to neviof a compound heterozygote proband with autosomal
Reverent Mosaicism by Mitotic Gene Conversion
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Figure 7. Diagram of Possible Mechanisms of Reverse Mutation during Mitosis in a Diploid Cell That Is Compound Heterozygous for an
Autosomal Recessive Mutation
Homologous chromosomes carry the paternal (blue) or maternal (pink) mutation. In each situation, loss of heterozygosity—homozygosity or
hemizygosity—is reached along the altered tract. Cells devoid of the protein are depicted white and cells with a revertant phenotype are
depicted green; solid for producing functional protein, and hatched for producing semi-functional protein. Note that gene conversion and
double crossing-over may result in the same revertant genotype; however, in the latter the revertant cells may theoretically be accompanied
by unique sister cells. It can be anticipated that these cells will disappear due to selective disadvantage.
(Happle, 1993; Paller et al., 1994). Since this phenome- were homozygous for a frameshift mutation (4003delTC)
in exon 52 of COL17A1 (McGrath et al., 1996). In contrastnon changes the phenotype from wild-type to a mutant
phenotype, we call this “forward mosaicism.” to our patient, their patient had no patches of clinically
unaffected skin. A possible explanation for this phenom-Somatic mosaicism may also develop after somatic
reverse mutation, i.e., the spontaneous correction of a enon might be mitotic gene deletion that restores the
reading frame in one of the two alleles or alternativedeleterious mutation during mitosis. The mosaic tissue
then contains revertant cells that stand out against the splicing with inframe skipping of the mutation. Either
way, the result is a shortened semifunctional protein withbackground of mutantcells. This condition can be desig-
nated “revertant mosaicism,” as opposed to forward recovered immunohistochemical staining properties in
a mosaic pattern (Figure 7).mosaicism. In revertant mosaicism, but not in forward
mosaicism, the parents carry the mutation. The selective advantage of type XVIIcollagen-positive
keratinocytes was more pronounced in vitro than in vivoThe mechanisms involved in somatic mutation are
characterized by loss of heterozygosity (Cavenee et al., in our proband: the amount of revertant keratinocytes
in culture was more than 98% of the total population,1983). Somatic cells become either homozygous at a
certain locus during mitotic recombination, resulting whereas this percentage did not reach beyond 50% in
the revertant skin patches. Only the appearance of newfrom a (double) crossing-over, gene conversion, or re-
verse point (back) mutation, or hemizygous resulting patches later in life and their slow expansion would
indicate that the selective advantage of revertant kera-from a nondisjunction or deletion (Figure 7).
tinocytes didalso happen in vivo. The type XVII collagen-
positive keratinocytes are probably monoclonal, derivedMicromosaicism within Revertant Skin
Examination of the clinically unaffected skin patches of from a single revertant progenitor cell, whereas the neg-
ative keratinocytes are possibly polyclonal and may de-the proband revealed that approximately 50% of the
basal cells expressed type XVII collagen in segments of rive from more than one mutant progenitor cell. It re-
mains to be resolved why culture conditions increase10–50 adjacent cells by immunofluorescence micros-
copy (Figure 2). These positive clusters may reflect the the selective disadvantage of mutant COL17A1 kera-
tinocytes.presence of cells supplied by divisions of revertant stem
cells. One of the patients of the original GABEB family Thus, at the cellular level, a micromosaicism could
be observed, consisting of a mixture of revertant anddescribed by Hinter and Wolf (1992) also had segments
of linear type XVII collagen staining in the skin (Pohla- mutant keratinocytes in the basal cell layer in the skin
patches. If this phenomenon also applies to forwardGubo et al., 1995). The affected members of this family
Cell
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mosaicism, one may expect wild-type keratinocytes in reversion has also been reported in liver nodules in pa-
tients with autosomal recessive tyrosinaemia type Iaddition to mutant keratinocytes in nevoid skin condi-
tions. caused by fumarylacetoacetate hydrolase (FAH) defi-
ciency (Kvittingen et al., 1994). The molecular mecha-The reversed allele in the proband was present only
in keratinocytes, which derive from ectoderm, whereas nism underlying the reverse mutation remained unre-
solved, although in some patients it could not be onit was undetectable in leukocytes and fibroblasts, which
derive from mesoderm. Furthermore, the bilateral distri- account of intragenic gene conversion, since the muta-
tion was homozygous.bution of the mosaic suggests that the reverse mutation
occurred before lateralization of the embryo was com-
pleted. This indicates that the reverse mutation occurred
Mitotic Gene Conversion of the Maternal Mutationbefore the late blastocyst stage in the second week
on the COL17A1 Gene Causes Epidermalof development. It is formally possible, however, that
Mosaicism in the Compoundfibroblast and haematopoietic progenitor cells con-
Heterozygous Probandtained also the reverse mutation but were not subject
Possible mechanisms, other than gene conversion, thatto natural selection, since type XVII collagen protein is
could account for the observed reverse mutation in ournot expressed by these cell types.
proband were excluded or found unlikely (Figure 7). De-The clinical mosaic phenotype with patches of normal
letion was excluded by PCR amplification of an ex-skin suggests that the reverse mutation led to reoccur-
tended segment of DNA from introns 16 to 19, and byrence of a functional type XVII collagen protein. It is
Western blotanalysis showing type XVIIcollagen proteinwell documented for COL17A1 that the presence of a
with normal length in revertant keratinocytes. Back mu-premature termination codon in both alleles leads to
tation (reverse point mutation) was excluded by showingunstable mRNA transcripts and undetectable protein
participation of a microsatellite in intron 18 in the reverselevels, similar to the findings in the proband’s clinically
mutation (Figure 6). Loss of heterozygosity by singleaffected skin (Figure 5, lanes 2 and 5) (Urlaub et al.,
crossing-over or chromosomal nondisjunction were ex-1989; McGrath et al., 1995). It is of interest that reversion
cluded by showing heterozygosity of flanking polymor-of 1706delA/R1226X to WT/R1226X COL17A1 genotype
phic markers. Theoretically, double crossing-over mightin 50% of the basal cells is sufficient to normalize skin
account for the loss of heterozygosity surrounding thefunction, even if the revertant cells produce lower
mutation, but the length of less than 5 cM of the homozy-amounts of type XVII collagen protein than the wild-type
gous tract makes this unlikely (Smithies and Powers,cells (Figure 5). Somatic gene therapy for certain genes
1986). Moreover, this genetic distance of 5 cM as deter-expressed in the skin might thus be successful if half,
mined in meiotic cell divisions (Gyapay et al., 1994) canor perhaps even less, of the basal cell population is
be considered as an overestimate of genetic distancereverted.
in mitosis, since recombinational activity in mitosis is
lower.
Our understanding of the molecular mechanismsSomatic Reversion and Mosaicism
Somatic reversion, i.e., reverse mutation during mitosis underlying gene conversion, a metaphor used for any
nonreciprocal exchange of homologous genetic infor-of a somatic cell, in higher eukaryotes was first encoun-
tered in hypothalamic neurons of the Brattleboro rat, mation, is mainly based on studies of meiotic recombi-
nation in lower eukaryotes, in which all the products ofwhich has a homozygous frame-shift mutation in the
arginine vasopressine gene (AVR), leading to diabetes a single meiosis can be recovered and analyzed. Gene
conversion during mitotic recombination is much lessinsipidus (Van Leeuwen et al., 1989). Reverse mutation
has also been documented in dystrophin-deficient mdx well documented. Because the latter is not possible in
mammals in vivo, nonreciprocicity of the genetic ex-mice (Hoffman et al., 1990) and in humans with Du-
chenne muscular dystrophy (Klein et al., 1992). In the change cannot formally be demonstrated. Despite this
limitation, the designation “gene conversion” has beenlatter, the mechanism was demonstrated to be an in-
frame skipping of the exon containing the mutation applied to exchanges observed in mammalian genomes
that involve an alteration of an allele in the range of a(Sherratt et al., 1993). The Duchenne mosaic phenotype
was not clinically recognizable, but only demonstrable few tens to a few thousands of nucleotides at a specific
locus in such a way that an internal portion of its se-by immunohistochemistry. Back mutation (reverse point
mutation), gene conversion, or single or double cross- quence has been replaced by a homologous segment
copied from another allele or locus (Smithies and Pow-ing-over are more effective than gene deletion (e.g.,
exon skipping), because with the former the wild-type ers, 1986).
In human, gene conversion has been postulated assequence is completely restored, reestablishing protein
function (Figure 7). an event that may occur during meiosis within several
gene families (OMIM, 1996), and mostly involves in-Recently, back mutation has been demonstrated to
cause reversion to normal of a deleterious missense tergenic exchange of DNA between pseudogene and
gene, leading to forward mutation. The gene conversionmutation on the maternal allele in a patient who was
compound heterozygous for autosomal recessive aden- observed in this study apparently occurred during mito-
sis, was at least in part intragenic, and led to reverseosine deaminase (ADA) deficiency (Hirschhorn et al.,
1996). According to the authors, the patient’s condition mutation.
For gene conversion, DNA breaks must occur to makeprogressively improved, due to the selective growth ad-
vantage of the revertant lymphocytes in vivo. Somatic sequence exchange between loci or alleles possible.
Reverent Mosaicism by Mitotic Gene Conversion
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anti-mouse IgG or goat anti-human IgG, followed by alkaline phos-According to the model of Kourilsky,single- and double-
phatase-conjugated rabbit anti-goat IgG.strand breaks may lead to distinct conversion events
(Kourilsky, 1986). In our proband, a double-strand break
Mutation Detection Strategy
may have occurred due to gamma or other ionizing radi- Genomic DNA was isolated from peripheral blood from the proband
ation in the DNA strand with the maternal allele leading and her parents, from (sorted) cultured keratinocytes, and from fi-
to its conversion by invasion of the paternal allele. The broblasts derived from clinically unaffected skin and affected fragile
skin of the proband (Miller et al., 1989). For amplification of all 56participation of the microsatellite, located 381 bp down-
known exons of the COL17A1 gene, primers based on the flankingstream from the maternal mutation, in the conversion
intronic sequences were synthesized (Gatalica et al., 1997).tract may not be coincidental. Several tetraplex recom-
For amplification of the 147 bp exon 51 containing the paternal
bination models have been suggested to explain mitotic mutation (nucleotide positions 3725–3871 in the COL17A1 cDNA;
gene conversion (Unrau and Johnson, 1995). Gene con- Giudice et al., 1992), the following primers were used: sense primer,
version plays a major role in controlling the stability 59-TTTCTCTCCTCCCATCACCC-39; antisense primer, 59-CCCTCCC
ACTTAAAGGGACA-39. The size of the expected amplification prod-of microsatellites in yeast (Gangloff et al., 1996). It is
uct was 374 bp. Amplification of the 222 bp exon 18 (nucleotidetempting to speculate that instability of the COL17A1-
positions 1571–1792 in the cDNA) containing the maternal mutationCA1 microsatellite in intron 18 might have led to DNA
utilized the following primers: sense primer, 59-AGGAGCGAGTGTAT
mismatch repair, which in turn evoked gene conversion GGAAGG-39; antisense primer, 5-9CAGCACATGCACACATACCA-39.
that reverted the maternal mutation in the coconversion The size of the expectedamplification product was 370bp. Detailsof
tract. the polymerase chain reaction (PCR) has been described elsewhere
(McGrath et al., 1995). Following PCR, aliquotsof 5 ml were examined
on a 2% agarose gel electrophoresis.Experimental Procedures
Heteroduplex analysis was performed by conformation-sensitive
gel electrophoresis on polyacrylamide gel (Ganguly et al., 1993).Cell Cultures
PCR products demonstrating heteroduplex bands (see Results)Keratinocytes and fibroblasts were cultured from 8 mm punch
were purified using a QIAquick PCR purification kit (Qiagen) andbiopsies from clinically unaffected skin and from perilesional skin
sequenced directly by an automated nucleotide sequencer (ABI)of the proband. Epidermis was separated from the dermis after
with the same primers as were used for initial PCR amplification.incubation with 0.03% trypsin, 0.01% EDTA.The harvested keratino-
cytes were cultured under serum-free conditions using keratinocyte
Verification of Mutationsgrowth medium (Clonetics, Inc.) according to Mitra and Nickoloff
For verification of the paternal mutation, 3781 C-to-T, which resulted(1994).
in the loss of a TaqI site (TCGA), the PCR product (10 ml) was
subjected to enzyme digestion (New England Biolabs). The digestion
Immunofluorescence Microscopy and Electron Microscopy products were electrophoresed on a 3.5% agarose gel. For verifica-
Snap frozen biopsies were taken from clinically unaffected skin tion of the maternal mutation, oligonucleotide probes covering the
(forearm) and from normal looking affected skin (forearm, upper sites of the mutation within exon 18 were designed for allele-specific
arm, and abdomen) of the proband. Skin biopsies were also taken oligonucleotide (ASO) hybridization of the PCR products spanning
from the upper arm of the parents. Monoclonal IgG1 antibodies 1D1 the mutation. A standard protocol was used (Christiano et al., 1994).
and 1A8c were directed against the extracellular and intracellular The probes were as follows: wild-type, 59-GCGGGAGCAGACCTGG
domains of type XVII collagen, respectively (Owaribe et al., 1991; ACAA-39; mutated allele, 59-GCGGGAGCAGCCTGGACAAA-39.
Nishizawa et al., 1993). The immunofluorescence staining proce-
dures for dual detection of type XVII collagen (moab 1D1) and inte-
Haplotype Analysisgrin b4 subunit (moab 439–9B, gift from Dr. S. J. Kennell) have been
To detect possible crossing-over, the alleles flanking the COL17A1detailed elsewhere (Jonkman et al., 1995). For immunofluorescence
gene on chromosome 10q24.3 were analyzed using microsatellitemicroscopy of cultured keratinocytes, cells were fixed with 1% form-
polymorphisms (Gyapay et al., 1994). The following flanking markersaldehyde, permeabilized with 0.5%Triton X-100, and incubated sub-
were used: D10S603 -3- D10S566 -5- [D10S597, D10S554] -6-sequently with 1A8c, fluorescein isothiocyanate-conjugated (FITC)
D10S562 -3- D10S542. Genetic distances in centimorgans are indi-goat anti-mouse IgG monoclonal antibody (Becton Dickinson, San
cated between the markers. The intragenic COL17A1 microsatelliteJose, CA), and FITC-rabbit anti-goat IgG monoclonalantibody (Dako
(COL17A1-CA1) in intron 18 (position 17921295) (Figure 6, middle)A/S, Glostrup, Denmark). Bizbenzimide was used as blue nuclear
was amplified as described elsewhere (H. S. et al., submitted). Thestain. For electron microscopy, routine procedures were followed
primers used for COL17A1-CA1 were: sense primer, 59-CAGGAAAAas previously described (Jonkman et al., 1992).
TGGTGGTGAGAGC-39; antisense primer 59-TCGGAGATTTCCTGCA
AGT-39.
Isolation of Type XVII Collagen-Positive Keratinocytes One base pair polymorphisms in the COL17A1 gene were de-
Frozen pellets of previously trypsinized cells were resuspended in tected by direct sequencing and, if possible, confirmed by restriction
ice-cold PBS. The cells were fixed with 1% paraformaldehyde and endonuclease digestion with the same method as described by
permeabilized with 0.3% saponin. 1A8c was chosen as primary verification of the mutation. The polymorphisms examined were in
antibody, since it recognizes the endodomain of type XVII collagen exon 10, 734 T/C (BsrD I); exon 14, 1168 T/C (DdeI); intron 19,
that remains intact after trypsinization. FITC labeling was achieved 1822114 T/C; exon 27, 2212 A/G; intron 28, 22681120 T/C (NlaIV);
as described above. Cells were sorted on a Coulter Epics-Elite exon 37, 2700 T/C (BstU I); and in exon 43, 2988 A/C (EcoO109 I)
equipped with a 15 mW 488 Argon laser. With the use of a conjugate (Gatalica et al., 1997).
staining (omitting the primary antibody), the nonspecific staining To rule out gene deletion, we amplified a 1892 bp product sur-
was estimated, which was then used to define the positive popu- rounding the maternal mutation (exon 18) from intron 16 (1373–64)
lation. to intron 19 (18221116) using the following primers: sense primer,
59-GAGAATCTGGAGGGAAAAGG-39; antisense primer, 5-9AGTCAT
TCAGCTCTTCATCC-39.Western Blot
For Western blot, extracts of cultured keratinocytes of proband’s In order to estimate the maximal length of the conversion tract,
introns 3 to 17 of COL17A1 gene were amplified, using primersunaffected and affected skin were used. SDS-polyacrylamide gel
electrophoresis and blotting were performed as described before based on the flanking exonic sequences (Gatalica et al., 1997). PCR
products were sequenced by an automated nucleotide sequencer(Pas et al., 1995). The primary antibodies used were moab 1A8c
and serum IgG from a patient with bullous pemphigoid. Bound anti- (ALF, Pharmacia) with the same primers as were used for initial PCR
amplification.bodies were detected by subsequent incubation with either goat
Cell
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